Mesenchymal stem cells (MSCs) are promising alternative agents for the treatment of
inflammatory disorders due to their immunomodulatory functions, and several clinical trials …

Recently, mesenchymal stromal cells (MSCs) and their derivative exosome have become a
promising approach in the context of liver diseases therapy, in particular, acute liver failure …

Umbilical cord Wharton's jelly‐derived mesenchymal stem cells (WJ‐MSCs) have recently
gained considerable attention in the field of regenerative medicine. Their high proliferation …

In recent years, mesenchymal stromal cells (MSCs) have generated a lot of attention due to
their paracrine and immuno-modulatory properties. mesenchymal stromal cells derived from …

Adipose derived stem cells (ADSCs) are popular in regenerative medicine due to their easy
availability, low immunogenicity and lack of controversy regarding their ethical debate use …

Acute-on-chronic liver failure (ACLF) is a severe syndrome associated with high mortality.
Alterations in the liver microenvironment are one of the vital causes of immune damage and …

The persistence of hepatotoxicity induced by N-acetyl-para-aminophenol (Acetaminophen
or Paracetamol, abbreviated as APAP) as the most common cause of acute liver failure in …

The route of administration of implanted cells may affect the outcome of cell therapy by
directing cell migration to the damaged site. However, the question of the relationship …

Preclinical animal models allow to study development and progression of several diseases,
including liver disorders. These studies, for ethical reasons and medical limits, are …

Background and Aims: Experimental models using carbon tetrachloride (CCl4) and D-
galactosamine (D-GalN) can be used in preclinical assessment of acute liver failure (ALF) …